Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:134-140
Published online before print October 26, 2006, doi: 10.1161/01.ATV.0000251020.24399.a2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/1/134    most recent
01.ATV.0000251020.24399.a2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, A. P.
Right arrow Articles by Moreno, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, A. P.
Right arrow Articles by Moreno, P. R.
Related Collections
Right arrow Oxidant stress
Right arrow Pathophysiology
Right arrow Genetically altered mice
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:134.)
© 2007 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque

Andrew P. Levy; Joanne E. Levy; Shiri Kalet-Litman; Rachel Miller-Lotan; Nina S. Levy; Roy Asaf; Julia Guetta; Chingwen Yang; K. Raman Purushothaman; Valentin Fuster; Pedro R. Moreno

From Technion Faculty of Medicine (A.P.L., S.K.-L., R.M.-L., N.S.L., R.A., J.G.), Technion-Israel Institute of Technology, Haifa, Israel; Division of Hematology and Oncology (J.E.L.), Children’s Hospital and Brigham and Women’s Hospital, Boston, Mass; Rockefeller University (C.Y.), New York, NY; Mount Sinai Medical Center (K.R.P., V.F., P.R.M.), New York, NY.

Correspondence to Andrew P. Levy, MD, PhD, Technion-Israel Institute of Technology, Haifa, Israel. E-mail alevy{at}tx.technion.ac.il

Objective— Intraplaque hemorrhage increases the risk of plaque rupture and thrombosis. The release of hemoglobin (Hb) from extravasated erythrocytes at the site of hemorrhage leads to iron deposition, which may increase oxidation and inflammation in the atherosclerotic plaque. The haptoglobin (Hp) protein is critical for protection against Hb-induced injury. Two common alleles exist at the Hp locus and the Hp 2 allele has been associated with increased risk of myocardial infarction. We have demonstrated decreased anti-oxidative and anti-inflammatory activity for the Hp 2 protein. We tested the hypothesis that the Hp 2-2 genotype is associated with increased oxidative and macrophage accumulation in atherosclerotic plaques.

Methods and Results— The murine Hp gene is a type 1 Hp allele. We created a murine type 2 Hp allele and targeted its insertion to the Hp locus by homologous recombination. Atherosclerotic plaques from C57Bl/6 ApoE–/– Hp 2-2 mice were associated with increased iron (P=0.008), lipid peroxidation (4-hydroxynonenal and ceroid) and macrophage accumulation (P=0.03) as compared with plaques from C57Bl/6 ApoE–/– Hp 1-1 mice.

Conclusions— Increased iron, lipid peroxidation and macrophage accumulation in ApoE–/– Hp 2-2 plaques suggests that the Hp genotype plays a critical role in the oxidative and inflammatory response to intraplaque hemorrhage.

We tested the hypothesis that the Hp genotype is a determinant of oxidative and inflammatory activity in atherosclerotic plaques. Plaques from Hp 2-2 mice were associated with increased iron, lipid peroxidation, and macrophage infiltration as compared with plaques from Hp 1-1 mice.


Key Words: atherosclerotic plaque • hemoglobin • inflammation • iron • macrophages




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Milman, S. Blum, C. Shapira, D. Aronson, R. Miller-Lotan, Y. Anbinder, J. Alshiek, L. Bennett, M. Kostenko, M. Landau, et al.
Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 341 - 347.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. L. Chaichana, A. P. Levy, R. Miller-Lotan, S. Shakur, and R. J. Tamargo
Haptoglobin 2-2 Genotype Determines Chronic Vasospasm After Experimental Subarachnoid Hemorrhage
Stroke, December 1, 2007; 38(12): 3266 - 3271.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. l. Sullivan
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Experimental Biology and Medicine, September 1, 2007; 232(8): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749.
[Full Text] [PDF]